The C Diff Foundation Has Declared an Urgent Need to Raise Clostridium difficile Infection Clinical Trial Awareness Worldwide
TAMPA, Fla. /ScoopCloud/ — The C Diff Foundation announced today that their organization has implemented a global campaign to raise awareness of Clostridioides difficile clinical trials, clinical studies, clinical research and observational studies evaluating interventions for C. difficile prevention, treatments, and environmental safety.
C Diff Foundation Recognizes Rebiotix CEO with 2019 ‘Above and Beyond’ Award
NEW PORT RICHEY, Fla. /ScoopCloud/ — The C. Diff Foundation Board of Directors announced today that the 2019 “Above and Beyond” Award will be presented to Rebiotix CEO Lee Jones in Roseville, Minnesota. The award, given to one recipient annually, is given to a person or organization that show extraordinary dedication to C. diff patient safety, advocacy, and overall drive to improve the lives of those impacted by the infection.
C Diff Foundation Presents Award to CutisPharma in Recognition of Contribution to C. diff. Community
NEW PORT RICHEY, Fla. /ScoopCloud/ — The C Diff Foundation today announced that it presented CutisPharma, Inc., its “Making a Difference” award as a special recognition of the significant contribution that CutisPharma has made to the C.diff. Community: helping the advancement of C.diff. awareness as well as expanding treatment options for C.diff. patients.
Clifford McDonald, MD and Alison Laufer-Halpin, Ph.D., of the CDC Discuss the Human Microbiome on C. diff. Spores and More
ATLANTA, Ga. /ScoopCloud/ — C Diff Foundation’s “C. diff. Spores and More Global Broadcasting Network” is honored to announce Doctors McDonald and Laufer-Halpin as our guest speakers on July 25, 2017 at 10 a.m. PT / 1 p.m. ET on C Diff Radio.
C Diff Foundation Announces Scholarship Program to Support Health Care Students
TAMPA, Fla. /ScoopCloud/ — The C Diff Foundation is pleased to announce the Michael and Helen Caralla, Sr. Educational Scholarship program. The scholarship program is to help health care students succeed and reach their educational goals.
‘C. diff. Science’ Honors Professionals Dedicated to Clostridium difficile Research and Development
TAMPA, Fla. /ScoopCloud/ — The C Diff Foundation hosts “C. diff. Science” on Sept. 14 to honor professionals dedicated to the scientific research and development in the Clostridium difficile (C. difficile, C. diff.) community worldwide, chaired by Professor Simon M. Cutting, PhD, of Molecular Microbiology at Royal Holloway, University of London.
Bake Sale to Raise C. diff. Awareness Starts in Florida Before Volunteers Roll-out Worldwide
TAMPA, Fla. /ScoopCloud/ — C Diff Foundation announces its “Bake Sale for C.diff. Awareness,” a month-long campaign beginning May 2017 in Florida and continuing in N.J., N.C., and across the USA to India, and Italy featuring education and advocacy on health care topics pertaining to the most common pathogen identified as a leading healthcare-associated infection (HAI) in U.S. hospitals alone: Clostridium difficile.
International Healthcare Experts Gather Nov. 9-10 in Las Vegas to Discuss Global Problems Around Leading Healthcare-acquired Infection Clostridium difficile
LAS VEGAS, Nev. /ScoopCloud/ — C Diff Foundation’s 5th Annual International C.diff. Awareness Conference and Health EXPO will be hosted in Las Vegas, Nev. on November 9 & 10, 2017 at UNLV-Thomas and Mack Center. A panel of C. diff. survivors will join world-renowned experts delivering presentations on health care topics pertaining to the most common pathogen identified, a leading healthcare-associated infection (HAI) in U.S. hospitals alone: Clostridium difficile (C.diff.).
C Diff Foundation’s 4th Annual International Raising C. diff. Awareness Conference and Health Expo 2016
TAMPA, Fla., May 6, 2016 (SEND2PRESS NEWSWIRE) — The C Diff Foundation ‘International Raising C. diff. Awareness’ Conference and Health Expo will be hosted in Atlanta on Sept. 20, 2016 featuring world-renowned experts delivering presentations on health care topics pertaining to the most common pathogen identified, a leading healthcare-associated infection (HAI) in U.S. hospitals alone: Clostridium difficile (C. diff.).
Taking Aim at Superbugs Discussed on C diff Spores and More Global Broadcasting Network with Dr Clifford McDonald of CDC
TAMPA, Fla., March 17, 2016 (SEND2PRESS NEWSWIRE) — C Diff Foundation, ‘C. diff. Spores and More,’ Global Broadcasting Network – innovative and educational interactive healthcare talk radio show discusses taking aim at ‘superbugs’ and the latest Vital Signs Report results with guest Dr. Clifford McDonald, MD on Tuesday, March 22, 2016 at 10 a.m. Pacific Time on VoiceAmerica Health and Wellness Channel.